Cadence OTC Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Crowdfunding
- (Announced)
- Latest Deal Amount
-
$1.42M
- Investors
-
13
Cadence OTC General Information
Description
Manufacturer of birth control pills intended to assist in the process of unwanted pregnancy. The company's product portfolio includes oral contraceptive pills under over-the-counter status and brings OTC emergency contraceptives to convenience stores without any prescription, enabling users to knock down the obstacles between women and reproductive health options.
Contact Information
Website
www.cadenceotc.comCorporate Office
- 1440 Broadway
- Suite 750
- Oakland, CA 94612
- United States
Corporate Office
- 1440 Broadway
- Suite 750
- Oakland, CA 94612
- United States
Cadence OTC Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Equity Crowdfunding | 05-Mar-2024 | $1.42M | 000.00 | Announced | Generating Revenue | |
| 6. Later Stage VC | 02-Jul-2024 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 5. Later Stage VC (Series C) | 01-Sep-2020 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Later Stage VC (Series B) | 01-Jan-2019 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Debt - General | 30-Apr-2018 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 22-Feb-2018 | $4.47M | $5.22M | 000.00 | Completed | Generating Revenue |
| 1. Angel (individual) | 21-Jan-2016 | $750K | $750K | Completed | Startup |
Cadence OTC Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series C-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.00 |
| Series B-1 | 2,653,928 | $0.000100 | $0.3 | $3.77 | $3.77 | 1x | $3.77 | 14.48% |
| Series A | 5,722,584 | $0.000100 | $0.12 | $1.47 | $1.47 | 1x | $1.47 | 31.23% |
Cadence OTC Comparisons
Industry
Financing
Details
000000
000000
Cadence OTC Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Consumer Brands | Private Equity-Backed | Pittsburgh, PA | 00 | 00000 | 000000000 | 00000 |
| Perrigo Company | Corporation | Dublin, Ireland | 0000 | 00.000 | 000000000 00 | 00.000 |
Cadence OTC Executive Team (8)
| Name | Title | Board Seat |
|---|---|---|
| Samantha Miller | Co-Founder, Chief Executive Officer & Board Member | |
| Carol Manchester | Chief Financial Officer | |
| Nathalie Nino | Chief Strategy Officer & Board Member | |
| Leo Santana | Controller | |
| Malcolm Potts Ph.D | Co-Founder & Scientific Advisor |
Cadence OTC Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Abigail Disney | Self | Board Member | 000 0000 |
| Constance Evans | Self | Board Member | 000 0000 |
| Gregory Martin | Shamrock Holdings | Board Observer | 000 0000 |
| Nathalie Nino | Cadence OTC | Chief Strategy Officer & Board Member | 000 0000 |
| Robert Hosang MD | Cadence OTC | Co-Founder, Chief Medical Officer & Board Member | 000 0000 |
Cadence OTC Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cadence OTC Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Argosy Foundation | Limited Partner | Minority | 000 0000 | 000000 0 |
| Jennifer Justice | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Shamrock Holdings | Family Office | Minority | 000 0000 | 000000 0 |
| Elizabeth Banks | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Sant Charitable Foundation | Corporation | Minority | 000 0000 | 000000 0 |
Cadence OTC FAQs
-
When was Cadence OTC founded?
Cadence OTC was founded in 2014.
-
Who is the founder of Cadence OTC?
Samantha Miller, Malcolm Potts Ph.D, and Robert Hosang MD are the founders of Cadence OTC.
-
Who is the CEO of Cadence OTC?
Samantha Miller is the CEO of Cadence OTC.
-
Where is Cadence OTC headquartered?
Cadence OTC is headquartered in Oakland, CA.
-
What is the size of Cadence OTC?
Cadence OTC has 10 total employees.
-
What industry is Cadence OTC in?
Cadence OTC’s primary industry is Pharmaceuticals.
-
Is Cadence OTC a private or public company?
Cadence OTC is a Private company.
-
What is Cadence OTC’s current revenue?
The current revenue for Cadence OTC is 000000.
-
How much funding has Cadence OTC raised over time?
Cadence OTC has raised $43.2M.
-
Who are Cadence OTC’s investors?
Argosy Foundation, Jennifer Justice, Shamrock Holdings, Elizabeth Banks, and Sant Charitable Foundation are 5 of 13 investors who have invested in Cadence OTC.
-
Who are Cadence OTC’s competitors?
Foundation Consumer Brands and Perrigo Company are competitors of Cadence OTC.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
